...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Topical Glucocorticoid Therapy Directly Induces Up-Regulation of Functional CXCR4 on Primed T Lymphocytes in the Aqueous Humor of Patients with Uveitis
【24h】

Topical Glucocorticoid Therapy Directly Induces Up-Regulation of Functional CXCR4 on Primed T Lymphocytes in the Aqueous Humor of Patients with Uveitis

机译:局部糖皮质激素治疗直接诱导葡萄膜炎患者水液中初生T淋巴细胞功能性CXCR4的上调

获取原文
获取原文并翻译 | 示例
           

摘要

Overexpression of the constitutive chemokine receptor CXCR4 has been shown to contribute to the accumulation of leukocytes at sites of chronic inflammation.Glucocorticoids are widely used to treat inflammatory disorders such as uveitis to considerable effect,yet paradoxically have been reported to increase CXCR4 expression in vitro.We show here that ocular lymphocytes isolated from patients with uveitis who had been treated with topical glucocorticoids expressed highly elevated levels of CXCR4.The up-regulation of CXCR4 could be reproduced in vitro by culture of CD4~+T cells with aqueous humor(AqH),indicating a role for the ocular microenvironment rather than preferential recruitment of CXCR4~+cells.Untreated uveitis and noninflammatory AqH up-regulated CXCR4 to a limited extent;this was dependent on TGF-beta2.However,the highest levels of CXCR4 both in vivo and in vitro were found in the glucocorticoid-treated patients.Glucocorticoids appeared to be directly responsible for the induction of CXCR4 in treated patients,as the glucocorticoid receptor antagonist RU38486 inhibited the in vitro up-regulation by AqH from these patients.Dexamethasone selectively up-regulated CXCR4 in vitro,but not any of a wide range of other chemokine receptors.CXCL12,the ligand for CXCR4,was present in AqH under noninflammatory conditions,but the levels were low in untreated uveitis and undetectable in treated uveitis AqH.The importance of these results for the treatment of HIV patients with glucocorticoids is discussed as well as a role for glucocorticoid-induced CXCR4 up-regulation and CXCL12 down-regulation in controlling the migration of lymphocyte populations,resulting in resolution of inflammation.
机译:已经证明组成型趋化因子受体CXCR4的过表达促进白细胞在慢性炎症部位的积累。糖皮质激素被广泛用于治疗诸如葡萄膜炎之类的炎性疾病,但据报道反常地增加了CXCR4的体外表达。我们在这里显示,从葡萄膜炎患者中分离的经局部糖皮质激素治疗的眼淋巴细胞表达了高水平的CXCR4.CXCR4的上调可以通过体外培养具有房水的CD4〜+ T细胞来复制。提示葡萄膜炎和非炎症性AqH在一定程度上上调了CXCR4;这取决于TGF-beta2。但是,体内CXCR4的最高水平糖皮质激素治疗的患者体内和体外均有发现。糖皮质激素似乎直接与诱导糖皮质激素受体拮抗剂RU38486抑制了这些患者体内AqH的上调。地塞米松选择性地上调了CXCR4的体外作用,但没有其他多种趋化因子受体的上调作用。 CXCR4的配体在非炎性条件下存在于AqH中,但在未经治疗的葡萄膜炎中水平较低,而在经过治疗的葡萄膜炎AqH中则无法检测到。诱导CXCR4上调和CXCL12下调,从而控制淋巴细胞的迁移,导致炎症消退。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号